Clinical Hypertension is the official journal of the Korean Society of Hypertension.
The Society is currently covering all publication costs so there are no article processing charges for authors.
Page 1 of 3
Hypertension is one of the most relevant risk factors in vascular aging, stroke and vascular dementia (VD). In the elderly, the prevalence of mixed dementia, which consists of Alzheimer’s disease (AD) and VD, ...
Citation: Clinical Hypertension 2019 25:27
The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnost...
Citation: Clinical Hypertension 2019 25:26
We have read with interest the Korean Society of Hypertension guidelines for the management of hypertension and congratulate the Society for an extensive review of literature while drafting the guidelines. The...
Citation: Clinical Hypertension 2019 25:25
17α-hydroxylase deficiency is a rare autosomal recessive disorder caused by mutations in the cytochrome P450 family 17 subfamily A member 1 gene. The major clinical presentation includes hypertension, hypokale...
Citation: Clinical Hypertension 2019 25:23
Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals ha...
Citation: Clinical Hypertension 2019 25:22
Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment. Large registry data of these patient populations have been published, although, phenotypic variants within ea...
Citation: Clinical Hypertension 2019 25:21
This study was performed to compare the associations of brachial-ankle pulse wave velocity (baPWV) and central blood pressure (CBP) measurements with left ventricular (LV) geometry and diastolic function.
Citation: Clinical Hypertension 2019 25:18
To explore the familial aggregation and heritability of hypertension in Han in Shanghai China.
Citation: Clinical Hypertension 2019 25:17
The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace the mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP mea...
Citation: Clinical Hypertension 2019 25:20
Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients’ characteristics. Additionally, the target b...
Citation: Clinical Hypertension 2019 25:19
The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been esta...
Citation: Clinical Hypertension 2019 25:16
Preeclampsia is a serious pregnancy-related disease which may lead to adverse health effects to the mother and fetus. Besides many publications on the association of red cell distribution width (RDW) and preec...
Citation: Clinical Hypertension 2019 25:15
Preeclampsia is leading causes of maternal and perinatal morbidity and mortality worldwide and it is a hypertensive disorder which usually occurs after 20 weeks of gestation. In Ethiopia, according to Ethiopia...
Citation: Clinical Hypertension 2019 25:14
The dysregulation of histone deacetylase (HDAC) protein expression or its enzyme activity is implicated in a variety of diseases. Cardiac HDAC6 and HDAC8 enzyme activity induced by deoxycorticosterone acetate ...
Citation: Clinical Hypertension 2019 25:13
Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We perform...
Citation: Clinical Hypertension 2019 25:12
Previous studies demonstrated that visit-to-visit variability of blood pressure (BP) has significant relationship with cardiovascular disease. Visit-to-visit variability in BP might have prognostic value for c...
Citation: Clinical Hypertension 2019 25:11
Neonatal hypertension is defined as persistent systolic and/or diastolic blood pressures above the 95th percentile compared to other infants of similar gestational age and size. Neonatal hypertension is a rare...
Citation: Clinical Hypertension 2019 25:10
Hypertension is the major risk factor for cardiovascular diseases and prevalence rates are critical to understanding the burden and envisaging health service requirements and resource allocation. We aimed to p...
Citation: Clinical Hypertension 2019 25:7
Every third patient in the clinic is misdiagnosed due to white-coat phenomenon, necessitating needless and costly treatment. We aimed to study the hemodynamic response of the physician’s visit on hypertensive ...
Citation: Clinical Hypertension 2019 25:8
Restriction of dietary salt is widely recommended in the management of hypertension, but assessment of individual salt intake has drawn little attention. Monitoring nutritional salt intake through sodium excre...
Citation: Clinical Hypertension 2019 25:3
Angina pectoris with a normal coronary angiogram, termed microvascular angina (MVA), is an important clinical entity; however, its causes remain unclear. Autonomic dysfunction is one of the possible causes. Th...
Citation: Clinical Hypertension 2019 25:4
BMI is an indicator commonly used in the world to measure the weight and height of the body, it reflects the comprehensive outcome of acquired lifestyle; FH is a sign reflecting the main role of genetic factor...
Citation: Clinical Hypertension 2019 25:6
The current gold standard for the diagnosis of white-coat effect is by the 24-h ambulatory blood pressure monitoring (ABPM) which may not be readily available in every primary care setting. Previous studies ha...
Citation: Clinical Hypertension 2019 25:2
A considerable proportion of cardiovascular events could be attributed to poor adherence to antihypertensive medications. Adverse effects can be severe enough to affect adherence to antihypertensive medication...
Citation: Clinical Hypertension 2019 25:1
In the original publication of this article [1], the reference number [42] under the section ‘vitamin D and Cardiovascular diseases’ (page no.2) should be [37].
Citation: Clinical Hypertension 2018 24:19
Randomized controlled trials can be expensive and time-consuming, leading to medical researchers utilizing real-world evidence (RWE) based on already-collected data. We aimed to conduct various RWE studies on ...
Citation: Clinical Hypertension 2018 24:18
Measures of the functional and structural properties of blood vessels can be used to assess preclinical stage of vascular disorders. Recent experimental and population studies show that arterial stiffening pre...
Citation: Clinical Hypertension 2018 24:17
Previous studies have suggested that the effects of medical interventions tend to diminish over time. We investigated whether the effects of blood pressure lowering treatment on all-cause mortality and stroke ...
Citation: Clinical Hypertension 2018 24:16
Hypokalemia in the presence of hypertension is often attributed to primary hyperaldosteronism as a cause of secondary hypertension, however secondary hyperaldosteronism may present similarly. Accessory renal a...
Citation: Clinical Hypertension 2018 24:15
It has been long debated whether menopause itself is a risk factor for hypertension in peri-menopausal women. We aimed to assess the association between menopause and hypertension, and whether metabolic syndro...
Citation: Clinical Hypertension 2018 24:14
The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea.
Citation: Clinical Hypertension 2018 24:13
Preeclampsia (PE) is a serious maternal complication during pregnancy. Associated arterial stiffness in PE patients leads to increased risks of cardiovascular diseases later in life. Cholesterol efflux capacit...
Citation: Clinical Hypertension 2018 24:11
Fimasartan (Kanarb; Boryung Pharmaceutical Co., Ltd., Seoul, Republic of Korea) is a non-protein angiotensin II receptor blocker that selectively blocks the AT1 receptor. No prior large-scale study has investi...
Citation: Clinical Hypertension 2018 24:10
Data are limited with regard to the relationship of albuminuria and major adverse cardiovascular events (MACE) in Chinese elder patients with high cardiovascular risk.
Citation: Clinical Hypertension 2018 24:12
Vitamin D, a fat-soluble prohormone, has wide-ranging roles in the regulation of many physiological processes through their interactions with the vitamin D receptors (VDR). It plays a major role in bones and c...
Citation: Clinical Hypertension 2018 24:9
Several diseases, such as obesity, hypertension and type 2 diabetes are frequently associated with metabolic abnormalities, high costs of healthcare and morbi-mortality; thus the aim of this study was to inves...
Citation: Clinical Hypertension 2018 24:8
The data on the association of sleep duration and blood pressure in the pediatric age group have been mixed and most studies have focused on weekday sleep duration. The purpose of this study was to compare the...
Citation: Clinical Hypertension 2018 24:7
Hypertension is the second most common cause of chronic kidney disease (CKD). Therefore, the aims of the study were to assess the knowledge, attitudes and practices (KAP) of hypertensive patients towards preve...
Citation: Clinical Hypertension 2018 24:6
Recent studies suggest an association between cytomegalovirus (CMV) infection and hypertension. In the present study, we used a variety of antigens and different assay methods to investigate the relationship b...
Citation: Clinical Hypertension 2018 24:5
We have read the study design “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic pa...
Citation: Clinical Hypertension 2018 24:4
A seemingly interesting observation in patients with sickle cell anaemia (SCA) is that they usually have lower systemic blood pressures (BP) and insulin resistance than persons in the general population in spi...
Citation: Clinical Hypertension 2018 24:3
This was a phase 3, randomized, double-blind, placebo-controlled study.
Citation: Clinical Hypertension 2018 24:2
Few data is available on the association between body mass index (BMI), serum uric acid (SUA) levels and blood pressure (BP) categories in the disease continuum, when efforts for its prevention may be applicable.
Citation: Clinical Hypertension 2018 24:1
Hypertension is the major contributor to cardiovascular diseases related morbidity and mortality. Blood pressure is not well controlled in the majority of patients with both diabetes and hypertension. The main...
Citation: Clinical Hypertension 2017 23:29
The use of impedance cardiography (ICG) may play a role in the assessment of cardiac effects of hypertension (HT), especially its hemodynamic features. Hypertensive heart disease involves structural changes an...
Citation: Clinical Hypertension 2017 23:28
Autonomic nervous system activity has been shown to be altered in patients with vasospastic angina (VA). Heart rate recovery (HRR) is a simple, non-invasive measurement of autonomic nervous system dysfunction....
Citation: Clinical Hypertension 2017 23:24
We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic paramet...
Citation: Clinical Hypertension 2017 23:27
The purpose of this survey was to evaluate the performance of hypertension screening in medical institutions conducting the national general health screening program of the Republic of Korea.
Citation: Clinical Hypertension 2017 23:23
Hypertension is one of the leading causes of disability and death in both developed and developing countries that need urgent strategies to implement interventions that control it. Appropriate lifestyle change...
Citation: Clinical Hypertension 2017 23:26
Carvedilol is used in the management of hypertension, ischemic heart disease, heart failure and most recently, portal hypertension. It has been associated with improved outcomes regarding variceal bleeding, he...
Citation: Clinical Hypertension 2017 23:25
Clinical Hypertension is the official journal of the Korean Society of Hypertension.
The Society is currently covering all publication costs so there are no article processing charges for authors.
Speed
49 days to first decision for reviewed manuscripts only
40 days to first decision for all manuscripts
105 days from submission to acceptance
23 days from acceptance to publication
Usage
69,698 Downloads
28 Altmetric Mentions